Jaguar Health issues Series F Preferred to SynWorld with 6B votes per share to facilitate reverse stock split

Jaguar Health, Inc.

Issued 10 shares of Series F Preferred to SynWorld Technologies for $100 total ($10/share).
Series F Preferred carries 6 billion votes per share, exercisable only on a proposed reverse stock split.
Reverse split ratio range: 1-for-3 to 1-for-75; board to set exact ratio before Jan 22, 2024.
Preferred shares mandate redemption within 3 business days after stockholder vote on reverse split.
Company will call a special meeting for stockholder approval of the reverse stock split amendment.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Jaguar Health, Inc.: Filed Certificate of Designation for Series F Preferred Stock, establishing the preferences, rights, and limitations of the new series (effective 2022-11-10).

Change: charter amendment
Effective: 2022-11-10

Exact text from the filing

The terms of the Series F Preferred Stock are set forth in a Certificate of Designation of Preferences, Rights and Limitations of Series F Preferred Stock (the “Certificate of Designation”) filed with the Secretary of State of Delaware (the “DE SOS”) and effective on November 10, 2022.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Jaguar Health, Inc. entered into Securities Purchase Agreement with SynWorld Technologies Corporation valued at $100 (effective 2022-11-11).

Action: entry
Agreement: equity purchase
Counterparty: SynWorld Technologies Corporation
Value: $100
Effective: 2022-11-11

Exact text from the filing

On November 11, 2022, Jaguar Health, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with SynWorld Technologies Corporation (“SynWorld”), pursuant to which the Company agreed to issue, in a private placement (the “Preferred Issuance Transaction”), an aggregate of ten shares (the “Series F Preferred Shares”) of the Company’s Series F Preferred Stock, par value $0.0001 per share (“Series F Preferred Stock”), at a price per share equal to the Series F Original Issue Price (as defined below) for gross proceeds of $100.

View on SEC.gov

18 governance changes filed in the last 30 days. Browse all governance changes →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-119584

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.